C-ARCH

V:ARCH - Arch Biopartners Inc. - http://www.archbiopartners.com

07:12:11 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
ARCH - V	0.4	1.68	·	1.73	3.0	1.70	+0.01	0.6	17.5	28	31	1.69 1.70 1.68	2.56 0.97	15:55:20	Apr 16	15 min RT 2¢
TSX-V - V	0.4	1.68	·	1.73	3.0	1.70	+0.01	0.6	11.5	18	18	1.69 1.70 1.68	2.56 0.97	15:55:20		15 min
NEO ATS - U						1.70	+0.01	0.6	0.1	0	1	1.70 1.70 1.70		14:19:36		15 min
Alpha - A						1.68	-0.01	-0.6	0.5	1	1	1.68 1.68 1.68		09:32:00		15 min
Omega - O						1.68	-0.01	-0.6	1.7	3	3	1.70 1.70 1.68		15:52:04		15 min
CX2 - H						1.68	-0.01	-0.6	1.6	3	2	1.70 1.70 1.68		15:52:04		15 min
CXD - D						1.69			0.004		1			May 16		15 min
TriAct - M						1.69			2.1	3	5			Sep 11-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 31

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:55:20	V	1.70	0.01	1,000	1 Anonymous	85 Scotia	K
15:52:04	O	1.68	-0.01	600	1 Anonymous	1 Anonymous	K
15:52:04	H	1.68	-0.01	600	1 Anonymous	79 CIBC	K
15:52:04	V	1.68	-0.01	100	1 Anonymous	79 CIBC	K
15:31:19	V	1.69		500	84 ITG84	1 Anonymous	K
15:31:19	V	1.69		100	7 TD Sec	1 Anonymous	K
15:04:42	M	1.71	0.02	18	7 TD Sec	7 TD Sec	E
15:00:42	M	1.69		36	80 National Bank	80 National Bank	E
14:20:28	V	1.70	0.01	800	1 Anonymous	9 BMO Nesbitt	K
14:19:36	O	1.70	0.01	100	1 Anonymous	9 BMO Nesbitt	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2024-04-16 11:51	C:ARCH	2.38	News Release200	Arch adds St. Michael's Hospital to LSALT trial
2024-04-03 10:26	C:ARCH	2.39	News Release200	Arch Biopartners welcomes UHN to LSALT phase II
2024-04-02 11:18	C:ARCH	2.30	News Release200	Arch Biopartners adds 3 sites to phase 2 LSALT trial
2024-03-18 10:41	C:ARCH	2.20	News Release200	Arch publishes phase II LSALT trial data in BMJ Open
2024-03-15 10:10	C:ARCH	2.20	News Release200	Arch adds University of Calgary to LSALT trial
2024-03-07 10:24	C:ARCH	1.56	News Release200	Arch doses 1st patient in phase II LSALT peptide trial
2024-02-27 12:03	C:ARCH	1.60	News Release200	Arch Biopartners completes pre-IND meeting with FDA
2024-01-10 08:45	C:ARCH	1.44	News Release200	Arch Biopartners okayed for phase 2 LSALT peptide trial
2024-01-03 10:32	C:ARCH	1.45	News Release200	Arch receives Turkish MoH OK for phase II LSALT trial
2023-12-21 11:04	C:ARCH	1.50	News Release200	Arch Biopartners receives Turkish LSALT phase II ok
2023-12-18 11:05	C:ARCH	1.45	News Release200	Arch Biopartners grants options to buy 350,000 shares
2023-12-13 11:08	C:ARCH	1.44	News Release200	Arch Biopartners applies for phase II LSALT trial
2023-11-09 16:34	C:ARCH	1.02	Shares for Debt330	Arch Biopartners 156,818 shares for debt
2023-10-24 12:58	C:ARCH	1.09	News Release200	Arch to settle $172,500 interest with shares
2023-09-22 09:21	C:ARCH	1.45	News Release200	Arch applies for LSALT peptide phase II trial in Turkey
2023-07-31 18:20	C:ARCH	2.07	News Release200	Arch Biopartners hires ITG as market-maker
2023-06-27 10:42	C:ARCH	2.14	News Release200	Arch Biopartners to proceed with phase 2 LSALT trial

Date ET

Symbol

Price

Type

Headline

2024-04-16 11:51

C:ARCH

2.38

News Release

Arch adds St. Michael's Hospital to LSALT trial

2024-04-03 10:26

C:ARCH